Searching map area
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.
? TBD
scientific article
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
D Ross Camidge
Subject
Endothelium
Pharmacology
Antibody
Monoclonal antibody
References
Wikidata